Drug firm Suven Life Sciences today reported 7.8 per cent increase in standalone net profit at Rs 40.06 crore for the fourth quarter ended March 2017. The company had posted a net profit of Rs 37.16 crore during the same period of last fiscal, Suven Life Sciences said in a BSE filing. For the entire fiscal, the company reported a consolidated net profit of Rs 87.18 crore. It had posted a net profit of Rs 71.84 crore in the 2015-16 fiscal. Its net sales for the fiscal stood at Rs 539.16 crore as compared to Rs 500.28 crore in the year-ago period.

Source: dna May 13, 2017 11:42 UTC